A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

Clinical trial NCT06807632 · RECRUITING

Trial details

NCT number: NCT06807632
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive-stage Small-cell Lung Cancer

Start date: 2025-01-29
Primary completion: 2027-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.